Sanofi-Aventis SA (SNY)

Add a New Bears Reason Company: Sanofi-Aventis SA (SNY) Current price: Headline: (100 character max) Analysis: Cancel 40% agree 10 votes   Highly concentrated in a few blockbuster drugs like Lovenex and Plavix Top Contributor: Jason Young | Created when NYSE:SNY was $40.93 | Edit | History Sanofi-Aventis revenues and profit are highly concentrated in a few blockbuster drugs like Lovenex and Plavix. Because of a lack of broad diversification, sanofi-Aventis is particularly vulnerable to patent challenges and expirations. (100 character max) Cancel 20% agree 5 votes   FDA refused to approve obesity drug Accomplia Top Contributor: Jason Young | Created when NYSE:SNY was $40.93 | Edit | History Sanofi-Aventis recently suffered a major setback when the Food and Drug Administration refused to approve obesity drug Accomplia, its most promising new product, for use in the United States. Accomplia, which is already marketed in 18 countries, was expected to achieve great success and propel growth in the company's US market. (100 character max) Cancel

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.